Compile Data Set for Download or QSAR
maximum 50k data
Found 234 with Last Name = 'guerini' and Initial = 'd'
TargetSignal peptide peptidase-like 2A(Homo sapiens)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50546132(CHEMBL4759048)
Affinity DataIC50:  4nMAssay Description:Inhibition of SPPL2a in human U2OS cells cotransfected with EGFP-labeled TNFalpha (1 to 76 residues)-NTF incubated for 24 hrs by Hoechst staining bas...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSignal peptide peptidase-like 2A(Mus musculus)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50546132(CHEMBL4759048)
Affinity DataIC50:  5nMAssay Description:Inhibition of mouse SPPL2a cotransfected with EGFP-NLP-fused TNFalpha (1 to 77 residues)-NTF incubated for 24 hrs by Hoechst staining based Cellomics...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSignal peptide peptidase-like 2A(Homo sapiens)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50262993(CHEMBL4059711)
Affinity DataIC50:  5nMAssay Description:Inhibition of human SPPL2a expressed in HEK293 cells using GAL4-VP16 fusedTNFalpha (1 to 76)-NTF as substrate after 24 hrs by Bright-Glo luciferase r...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSignal peptide peptidase-like 2A(Homo sapiens)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50263008(CHEMBL255473)
Affinity DataIC50:  6nMAssay Description:Inhibition of human SPPL2a expressed in HEK293 cells using GAL4-VP16 fusedTNFalpha (1 to 76)-NTF as substrate after 24 hrs by Bright-Glo luciferase r...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSignal peptide peptidase-like 2A(Homo sapiens)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50546130(CHEMBL4762492)
Affinity DataIC50:  7nMAssay Description:Inhibition of human SPPL2a expressed in HEK293 cells cotransfected with Gal4 luciferase reporter plasmid and VP16-TNFalpha(1-76)-NTF incubated for 24...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSignal peptide peptidase-like 2A(Homo sapiens)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50546132(CHEMBL4759048)
Affinity DataIC50:  9nMAssay Description:Inhibition of human SPPL2a expressed in HEK293 cells cotransfected with Gal4 luciferase reporter plasmid and VP16-TNFalpha(1-76)-NTF incubated for 24...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSignal peptide peptidase-like 2A(Homo sapiens)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50241259((2S)-2-((S)-2-(3,5-difluorophenyl)-2-hydroxyacetam...)
Affinity DataIC50:  10nMAssay Description:Inhibition of human SPPL2a expressed in HEK293 cells using GAL4-VP16 fusedTNFalpha (1 to 76)-NTF as substrate after 24 hrs by Bright-Glo luciferase r...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSignal peptide peptidase-like 2A(Homo sapiens)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50546128(CHEMBL4753654)
Affinity DataIC50:  13nMAssay Description:Inhibition of human SPPL2a expressed in HEK293 cells cotransfected with Gal4 luciferase reporter plasmid and VP16-TNFalpha(1-76)-NTF incubated for 24...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSignal peptide peptidase-like 2A(Homo sapiens)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50546125(CHEMBL4792187)
Affinity DataIC50:  15nMAssay Description:Inhibition of human SPPL2a expressed in HEK293 cells cotransfected with Gal4 luciferase reporter plasmid and VP16-TNFalpha(1-76)-NTF incubated for 24...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSignal peptide peptidase-like 2A(Homo sapiens)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50546131(CHEMBL4759943)
Affinity DataIC50:  25nMAssay Description:Inhibition of human SPPL2a expressed in HEK293 cells cotransfected with Gal4 luciferase reporter plasmid and VP16-TNFalpha(1-76)-NTF incubated for 24...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCyclic GMP-AMP synthase [147-522](Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM651804(5-(6-chloro-5-methoxy-3-(1H- pyrazol-4-yl)-1H-pyrr...)
Affinity DataIC50:  30nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following: 50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitrog...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCyclic GMP-AMP synthase [147-522](Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM651803(6-chloro-2-(5-(1,1-difluoro-2- methoxyethyl)-4H-1,...)
Affinity DataIC50:  30nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following: 50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitrog...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCyclic GMP-AMP synthase [147-522](Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM651791(6-chloro-2-(5-(1,1-difluoro- ethyl)-4H-1,2,4-triaz...)
Affinity DataIC50:  32nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following: 50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitrog...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetSignal peptide peptidase-like 2A(Homo sapiens)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50262979(CHEMBL4077007)
Affinity DataIC50:  35nMAssay Description:Inhibition of human SPPL2a expressed in HEK293 cells using GAL4-VP16 fusedTNFalpha (1 to 76)-NTF as substrate after 24 hrs by Bright-Glo luciferase r...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSignal peptide peptidase-like 2A(Homo sapiens)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50263007(CHEMBL4076827)
Affinity DataIC50:  44nMAssay Description:Inhibition of human SPPL2a expressed in HEK293 cells using GAL4-VP16 fusedTNFalpha (1 to 76)-NTF as substrate after 24 hrs by Bright-Glo luciferase r...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclic GMP-AMP synthase [147-522](Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM651815(2-(5-(6-chloro-3-(1H-imidazol- 1-yl)-5-methoxy-1-m...)
Affinity DataIC50:  45nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following: 50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitrog...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetSignal peptide peptidase-like 2A(Mus musculus)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50263007(CHEMBL4076827)
Affinity DataIC50:  50nMAssay Description:Inhibition of SPPL2a in mouse whole blood assessed as increase in CD74/p8 accumulation after 5.5 hrs by Western bot methodMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclic GMP-AMP synthase [147-522](Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM651822(2-(5-(6-chloro-3-(1H-imidazol- 1-yl)-5-methoxy-1-m...)
Affinity DataIC50:  54nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following: 50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitrog...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCyclic GMP-AMP synthase [147-522](Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM651796(6-chloro-2-(5-(1,1-difluoro-2- methoxyethyl)-4H-1,...)
Affinity DataIC50:  55nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following: 50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitrog...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetSimilar to RIKEN cDNA 2010106G01 (Predicted)(Rattus norvegicus)
The Genomics Institute of The Novartis Research Foundation

Curated by ChEMBL
LigandPNGBDBM50263004(CHEMBL4069936)
Affinity DataIC50:  56nMAssay Description:Inhibition of rat SPPL2a expressed in human U2OS cells using EGFP-labeled TNFalpha (1 to 77 residues) NLS as substrate after 24 hrs by Hoechst staini...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclic GMP-AMP synthase [147-522](Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM651816(1-(5-(6-chloro-3-(1H-imidazol- 1-yl)-5-methoxy-1-m...)
Affinity DataIC50:  61nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following: 50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitrog...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCyclic GMP-AMP synthase [147-522](Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM651798(6-chloro-2-(5-fluoro-4H- 1,2,4-triazol-3-yl)-5-met...)
Affinity DataIC50:  63nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following: 50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitrog...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCyclic GMP-AMP synthase [147-522](Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM651830(1-(5-(6-chloro-5-methoxy-1- methyl-3-(1H-pyrazol-4...)
Affinity DataIC50:  66nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following: 50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitrog...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCyclic GMP-AMP synthase [147-522](Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM651794(1-(5-(6-chloro-5-methoxy-3- (1H-pyrazol-4-yl)-1H- ...)
Affinity DataIC50:  66nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following: 50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitrog...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCyclic GMP-AMP synthase [147-522](Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM651829(6-chloro-5-methoxy-1-methyl- 3-(1H-pyrazol-4-yl)-2...)
Affinity DataIC50:  67nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following: 50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitrog...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetSignal peptide peptidase-like 2A(Homo sapiens)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50262968(CHEMBL4064631)
Affinity DataIC50:  70nMAssay Description:Inhibition of human SPPL2a expressed in HEK293 cells using GAL4-VP16 fusedTNFalpha (1 to 76)-NTF as substrate after 24 hrs by Bright-Glo luciferase r...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclic GMP-AMP synthase [147-522](Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM651789(6-chloro-5-methoxy-1-methyl- 3-(1H-pyrazol-4-yl)-2...)
Affinity DataIC50:  76nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following: 50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitrog...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetSignal peptide peptidase-like 2A(Homo sapiens)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50263010(CHEMBL4100749)
Affinity DataIC50:  76nMAssay Description:Inhibition of human SPPL2a expressed in HEK293 cells using GAL4-VP16 fusedTNFalpha (1 to 76)-NTF as substrate after 24 hrs by Bright-Glo luciferase r...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSignal peptide peptidase-like 2A(Homo sapiens)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50263004(CHEMBL4069936)
Affinity DataIC50:  77nMAssay Description:Inhibition of human SPPL2a expressed in HEK293 cells using GAL4-VP16 fusedTNFalpha (1 to 76)-NTF as substrate after 24 hrs by Bright-Glo luciferase r...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclic GMP-AMP synthase [147-522](Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM651832(6-chloro-2-(5-(1,2-dimethoxy- ethyl)-4H-1,2,4-tria...)
Affinity DataIC50:  77nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following: 50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitrog...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetSignal peptide peptidase-like 2A(Homo sapiens)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50263004(CHEMBL4069936)
Affinity DataIC50:  77nMAssay Description:Inhibition of human ERG expressed in HEK293 cells assessed as decrease in peak tail current amplitude by path clamp methodMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclic GMP-AMP synthase [147-522](Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM651819(6-chloro-2-(5-(1,1-difluoro- ethyl)-4H-1,2,4-triaz...)
Affinity DataIC50:  79nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following: 50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitrog...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCyclic GMP-AMP synthase [147-522](Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM651834(6-chloro-3-(1H-imidazol-1-yl)- 5-methoxy-2-(5-(tri...)
Affinity DataIC50:  80nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following: 50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitrog...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetSignal peptide peptidase-like 2A(Homo sapiens)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50546124(CHEMBL4740837)
Affinity DataIC50:  88nMAssay Description:Inhibition of human SPPL2a expressed in HEK293 cells cotransfected with Gal4 luciferase reporter plasmid and VP16-TNFalpha(1-76)-NTF incubated for 24...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCyclic GMP-AMP synthase [147-522](Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM651835(6-chloro-5-methoxy-3-(1H- pyrazol-4-yl)-2-(5-(trif...)
Affinity DataIC50:  91nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following: 50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitrog...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCyclic GMP-AMP synthase [147-522](Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM651810(6-chloro-2-(5-(2,2-difluoro-1- methoxyethyl)-4H-1,...)
Affinity DataIC50:  93nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following: 50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitrog...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCyclic GMP-AMP synthase [147-522](Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM651793(2-(5-(6-chloro-5-methoxy-3- (1H-pyrazol-4-yl)-1H- ...)
Affinity DataIC50:  97nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following: 50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitrog...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetSignal peptide peptidase-like 2A(Mus musculus)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50263007(CHEMBL4076827)
Affinity DataIC50:  97nMAssay Description:Inhibition of mouse SPPL2a in A20 cells assessed as CD74/p8 accumulation by flow cytometryMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclic GMP-AMP synthase [147-522](Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM651831(5-(6-chloro-5-methoxy-1-meth- yl-3-(1H-pyrazol-4-y...)
Affinity DataIC50:  98nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following: 50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitrog...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCyclic GMP-AMP synthase [147-522](Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM651828((E)-1-(5-(6-chloro-3-(1H- imidazol-1-yl)-5-methoxy...)
Affinity DataIC50:  101nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following: 50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitrog...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCyclic GMP-AMP synthase [147-522](Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM651814(6-chloro-3-(1H-imidazol-1-yl)- 5-methoxy-1-methyl-...)
Affinity DataIC50:  107nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following: 50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitrog...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCyclic GMP-AMP synthase [147-522](Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM651812(2-(1-(5-(6-chloro-3-(1H- imidazol-1-yl)-5-methoxy-...)
Affinity DataIC50:  114nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following: 50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitrog...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCyclic GMP-AMP synthase [147-522](Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM651805(5-(6-chloro-3-(1H-imidazol-1- yl)-5-methoxy-1-meth...)
Affinity DataIC50:  116nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following: 50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitrog...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetSignal peptide peptidase-like 2A(Mus musculus)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50263010(CHEMBL4100749)
Affinity DataIC50:  121nMAssay Description:Inhibition of mouse SPPL2a in A20 cells assessed as CD74/p8 accumulation by flow cytometryMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCyclic GMP-AMP synthase [147-522](Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM651809(1-(5-(6-chloro-3-(1H-imidazol- 1-yl)-5-methoxy-1-m...)
Affinity DataIC50:  121nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following: 50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitrog...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCyclic GMP-AMP synthase [147-522](Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM651801(6-chloro-2-(5-chloro-4H- 1,2,4-triazol-3-yl)-5-met...)
Affinity DataIC50:  122nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following: 50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitrog...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCyclic GMP-AMP synthase [147-522](Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM651825(1-(5-(6-chloro-5-methoxy-1- methyl-3-(1H-pyrazol-4...)
Affinity DataIC50:  123nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following: 50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitrog...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCyclic GMP-AMP synthase [147-522](Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM651790(6-chloro-2-(5-(1,1-difluoro- ethyl)-4H-1,2,4-triaz...)
Affinity DataIC50:  124nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following: 50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitrog...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetSignal peptide peptidase-like 2A(Mus musculus)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50263004(CHEMBL4069936)
Affinity DataIC50:  137nMAssay Description:Inhibition of human ERG expressed in HEK293 cells assessed as decrease in peak tail current amplitude by path clamp methodMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclic GMP-AMP synthase [147-522](Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM651811(6-chloro-2-(5-(1,2-dimethoxy- ethyl)-4H-1,2,4-tria...)
Affinity DataIC50:  144nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following: 50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitrog...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
Displayed 1 to 50 (of 234 total ) | Next | Last >>
Jump to: